undamentalytics Newsletter

Astrotech Corp income statement

In fiscal 2026, Astrotech Corp reported revenue of $913,000, down 8.7% on the year before, operating income of −$14.1m (a -1548.5% margin) and net income of −$14.4m. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Astrotech Corp: income statement, annual
Fiscal year2011Jun 20112012Jun 20122013Jun 20132014Jun 20142015Jun 20152016Jun 20162017Jun 20172018Jun 20182019Jun 20192020Jun 20202021Jun 20212022Jun 20222023Jun 20232024Jun 20242025Jun 20252026Jun 2026
Revenue2026240132000011211
Cost of revenue1419160021000010111
Gross profit6780001000000100
Research and development4323366643336786
Selling, general and administrative87781388655566778
Operating income−6−2−1−10−16−14−12−13−8−8−8−9−11−13−15−14
Interest expense———00———————————
Income before tax−6−3−1−10−16−13−12−13−8−8−8−8−10−12−14−14
Income tax−000−4−6−000−10000000
Net income−5−3−0−511−13−12−13−8−8−8−8−10−12−14−14
Diluted EPS−$42.00−$22.50$1.50$37.50$78.00−$19.20−$85.20−$97.80−$45.90−$39.30−$10.50—————
Diluted shares (average)———————————2m2m2m2m2m
EBITDA−3−02−10−16−13−11−13−8−8−8−8−11−13−14−13

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: ASTC vs QSIASTC vs BGLCASTC vs YDES

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Astrotech Corp's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Astrotech Corp.